# Real-world outcomes of immunotherapy–based regimens in first-line advanced non-small cell lung cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/real-world-outcomes-of-immunotherapy-based-regimens-in-first-line-advanced-non/

## Facts

| Field | Value |
| --- | --- |
| Author Names | David Waterhouse,Jenny Lam,Keith A. Betts,Lei Yin,Sophie Gao,Yong Yuan,John Hartman,Sumati Rao,Solomon J. Lubinga,David D. Stenehjem |
| Citations | 142 |
| DOI | 10.1016/j.lungcan.2021.04.007 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | http://www.lungcancerjournal.info/article/S0169500221001355/pdf |
| OpenAlex ID | https://openalex.org/W3153504580 |
| PMID | 33894493 |
| Type | article |
| Year | 2021 |

## Paper authors

- [David D. Stenehjem](https://scholariq.org/researchers/david-d-stenehjem/)

## Paper journal

- [Lung Cancer](https://scholariq.org/journals/lung-cancer/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.